Publications by authors named "Maria Labrou"

Claim this Profile
I
Integrated Deadenylase Genetic Association Network and Transcriptome Analysis in Thoracic Carcinomas.
Athanasios Kyritsis, Eirini Papanastasi, Ioanna Kokkori, Panagiotis Maragozidis, Demetra S M Chatzileontiadou, Maria Labrou

Molecules· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Tigecycline in combination with Colistin, Meropenem, Rifampin, or Gentamicin against KPC-producing Enterobacteriaceae in a murine thigh infection model.
George Michail, Maria Labrou, Vassiliki Pitiriga, Styliani Manousaka, Nikolaos Sakellaridis

Antimicrob Agents Chemother· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations of deadenylase expression in acute leukemias: evidence for poly(a)-specific ribonuclease as a potential biomarker.
Panayiotis Maragozidis, Maria Karangeli, Maria Labrou, Georgia Dimoulou, Konstantia Papaspyrou

Acta Haematol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.
Eleni Ntokou, Constantinos Stathopoulos, Ioulia Kristo, Evangelia Dimitroulia, Maria Labrou

J Antimicrob Chemother· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of oxacillin versus that of vancomycin against oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates evaluated by population analyses, time-kill assays, and a murine thigh infection model.
Maria Labrou, George Michail, Eleni Ntokou, Theodore E Pittaras, Spyros Pournaras

Antimicrob Agents Chemother· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in biofilm formation and virulence factors between clinical and fecal enterococcal isolates of human and animal origin.
Giorgos Tsikrikonis, Antonios N Maniatis, Maria Labrou, Eleni Ntokou, Giorgos Michail

Microb Pathog· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of mutations in the FemXAB protein family in oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates.
Stamatina Giannouli, Maria Labrou, Athanassios Kyritsis, Alexandros Ikonomidis, Spyros Pournaras

J Antimicrob Chemother· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo evaluations of oxacillin efficiency against mecA-positive oxacillin-susceptible Staphylococcus aureus.
Alexandros Ikonomidis, George Michail, Afroditi Vasdeki, Maria Labrou, Vasilis Karavasilis

Antimicrob Agents Chemother· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12.
Alexandros Ikonomidis, Maria Labrou, Zoe Afkou, Antonios N Maniatis, Danai Sofianou

Antimicrob Agents Chemother· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis